Publications of Martin Begemann
All genres
Journal Article (54)
2013
Journal Article
13, 218 (2013)
Odor naming and interpretation performance in 881 schizophrenia subjects: association with clinical parameters. BMC Psychiatry
Journal Article
19, pp. 135 - 148 (2013)
Genetic markers of Munc13 protein family member, BAIAP3, are gender-specifically associated with anxiety and benzodiazepine abuse in mouse and man. Molecular Medicine
Journal Article
3, e254 (2013)
A single gene defect causing claustrophobia. Translational Psychiatry 2012
Journal Article
4 (6), pp. 528 - 539 (2012)
A myelin gene causative of a catatonia-depression syndrome upon aging. Embo Molecular Medicine
Journal Article
18, pp. 1029 - 1040 (2012)
Common variants of the genes encoding erythropoietin and its receptor modulate cognitive performance in schizophrenia. Molecular Medicine 2011
Journal Article
Dissociation of accumulated genetic risk and disease severity in patients with schizophrenia. Translational Psychiatry, e45 (2011)
Journal Article
68 (12), pp. 1247 - 1256 (2011)
Prediction of the risk of comorbid alcoholism in schizophrenia by interaction of common genetic variants in the corticotropin-releasing factor system. Archives of General Psychiatry
Journal Article
156 (3), pp. 340 - 345 (2011)
A phenotype-based genetic association study reveals the contribution of neuregulin1 gene variants to age of onset and positive symptom severity in schizophrenia. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics
Journal Article
3 (6), pp. 309 - 319 (2011)
A CAG repeat polymorphism of KCNN3 predicts SK3 channel function and cognitive performance in schizophrenia. Embo Molecular Medicine
Journal Article
16 (1), pp. 26 - 36 (2011)
Recombinant human erythropoietin delays loss of gray matter in chronic schizophrenia. Molecular Psychiatry
Journal Article
16, 1 (2011)
EPO treatment preserves gray matter in discrete brain regions of chronic schizophrenic patients: indication of areas with most progressive neurodegeneration inherent to the disease process. Molecular Psychiatry 2010
Journal Article
10, 91 (2010)
The cross-sectional GRAS sample: a comprehensive phenotypical data collection of schizophrenic patients. BMC Psychiatry
Journal Article
67 (9), pp. 879 - 888 (2010)
Modification of cognitive performance in schizophrenia by complexin 2 gene polymorphisms. Archives of General Psychiatry 2008
Journal Article
14 (9-10), pp. 546 - 552 (2008)
Episode-specific differential gene expression of peripheral blood mononuclear cells in rapid cycling supports novel treatment approaches. Molecular Medicine